Alyeska Investment Group, L.P. Oyster Point Pharma, Inc. Transaction History

Alyeska Investment Group, L.P.

  • $18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
BUY
$18.13 - $25.18 $51,235 - $71,158
2,826 Added 14.82%
21,898 $412,000
Q3 2020

Nov 16, 2020
SELL
$17.83 - $29.12 $1.31 Million - $2.15 Million
-73,710 Reduced 79.44%
19,072 $402,000
Q2 2020

Aug 14, 2020
BUY
$27.86 - $35.93 $2.58 Million - $3.33 Million
92,782 New
92,782 $2.68 Million

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email